Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial
Background:
The incidence of acute kidney injury (AKI) is increasing globally and it is much more common than end-stage kidney disease. AKI is associated with high mortality and cost of hospitalisation. Studies of treatments to reduce this high mortality have used differing renal replacement therapy (RRT) modalities and have not shown improvement in the short term. The reported long-term outcomes of AKI are variable and the effect of differing RRT modalities upon them is not clear. We used the prolonged follow-up of a large clinical trial to prospectively examine the long-term outcomes and effect of RRT dosing in patients with AKI.
Methods and Findings:
We extended the follow-up of participants in the Randomised Evaluation of Normal vs. Augmented Levels of RRT (RENAL) study from 90 days to 4 years after randomization. Primary and secondary outcomes were mortality and requirement for maintenance dialysis, respectively, assessed in 1,464 (97%) patients at a median of 43.9 months (interquartile range [IQR] 30.0–48.6 months) post randomization. A total of 468/743 (63%) and 444/721 (62%) patients died in the lower and higher intensity groups, respectively (risk ratio [RR] 1.04, 95% CI 0.96–1.12, p = 0.49). Amongst survivors to day 90, 21 of 411 (5.1%) and 23 of 399 (5.8%) in the respective groups were treated with maintenance dialysis (RR 1.12, 95% CI 0.63–2.00, p = 0.69). The prevalence of albuminuria among survivors was 40% and 44%, respectively (p = 0.48). Quality of life was not different between the two treatment groups. The generalizability of these findings to other populations with AKI requires further exploration.
Conclusions:
Patients with AKI requiring RRT in intensive care have high long-term mortality but few require maintenance dialysis. Long-term survivors have a heavy burden of proteinuria. Increased intensity of RRT does not reduce mortality or subsequent treatment with dialysis.
Trial registration:
www.ClinicalTrials.gov NCT00221013
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial. PLoS Med 11(2): e32767. doi:10.1371/journal.pmed.1001601
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001601
Souhrn
Background:
The incidence of acute kidney injury (AKI) is increasing globally and it is much more common than end-stage kidney disease. AKI is associated with high mortality and cost of hospitalisation. Studies of treatments to reduce this high mortality have used differing renal replacement therapy (RRT) modalities and have not shown improvement in the short term. The reported long-term outcomes of AKI are variable and the effect of differing RRT modalities upon them is not clear. We used the prolonged follow-up of a large clinical trial to prospectively examine the long-term outcomes and effect of RRT dosing in patients with AKI.
Methods and Findings:
We extended the follow-up of participants in the Randomised Evaluation of Normal vs. Augmented Levels of RRT (RENAL) study from 90 days to 4 years after randomization. Primary and secondary outcomes were mortality and requirement for maintenance dialysis, respectively, assessed in 1,464 (97%) patients at a median of 43.9 months (interquartile range [IQR] 30.0–48.6 months) post randomization. A total of 468/743 (63%) and 444/721 (62%) patients died in the lower and higher intensity groups, respectively (risk ratio [RR] 1.04, 95% CI 0.96–1.12, p = 0.49). Amongst survivors to day 90, 21 of 411 (5.1%) and 23 of 399 (5.8%) in the respective groups were treated with maintenance dialysis (RR 1.12, 95% CI 0.63–2.00, p = 0.69). The prevalence of albuminuria among survivors was 40% and 44%, respectively (p = 0.48). Quality of life was not different between the two treatment groups. The generalizability of these findings to other populations with AKI requires further exploration.
Conclusions:
Patients with AKI requiring RRT in intensive care have high long-term mortality but few require maintenance dialysis. Long-term survivors have a heavy burden of proteinuria. Increased intensity of RRT does not reduce mortality or subsequent treatment with dialysis.
Trial registration:
www.ClinicalTrials.gov NCT00221013
Please see later in the article for the Editors' Summary
Zdroje
1. AliT, KhanI, SimpsonW, PrescottG, TownendJ, et al. (2007) Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 18: 1292–1298.
2. BagshawSM, GeorgeC, BellomoR (2007) Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 11: R68.
3. CerdaJ, LameireN, EggersP, PannuN, UchinoS, et al. (2008) Epidemiology of acute kidney injury. CJASN 3: 881–886.
4. UchinoS, KellumJA, BellomoR, DoigGS, MorimatsuH, et al. (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813–818.
5. WaldR, QuinnRR, LuoJ, LiP, ScalesDC, et al. (2009) Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302: 1179–1185.
6. LoLJ, GoAS, ChertowGM, McCullochCE, FanD, et al. (2009) Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893–899.
7. ChoiAI, LiY, ParikhC, VolberdingPA, ShlipakMG (2010) Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int 78: 478–485.
8. NewsomeBB, WarnockDG, McClellanWM, HerzogCA, KiefeCI, et al. (2008) Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 168: 609–616.
9. IshaniA, XueJL, HimmelfarbJ, EggersPW, KimmelPL, et al. (2009) Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223–228.
10. IshaniA, XueJL, HimmelfarbJ, EggersPW, KimmelPL, et al. (2009) Acute Kidney Injury Increases Risk of ESRD among Elderly. J Am Soc Nephrol 20: 223–228.
11. CocaSG, SinganamalaS, ParikhCR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81: 442–448.
12. JunM, HeerspinkHJ, NinomiyaT, GallagherM, BellomoR, et al. (2010) Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 5: 956–963.
13. BellomoR, CassA, ColeL, FinferS, GallagherM, et al. (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361: 1627–1638.
14. Renal Study Investigators (2008) BellomoR, CassA, ColeL, FinferS, et al. (2008) Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: high-dose versus standard-dose hemofiltration in acute renal failure. Blood Purificat 26: 407–416.
15. LeveyAS, BoschJP, LewisJB, GreeneT, RogersN, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461–470.
16. EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16: 199–208.
17. WareJJr, KosinskiM, KellerSD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34: 220–233.
18. BoneRC, BalkRA, CerraFB, DellingerRP, FeinAM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Crit Care Med. Chest 101: 1644–1655.
19. KnausWA, WagnerDP, DraperEA, ZimmermanJE, BergnerM, et al. (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100: 1619–1636.
20. VincentJL, de MendoncaA, CantraineF, MorenoR, TakalaJ, et al. (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26: 1793–1800.
21. GrayRJ (1988) A class of K-sample tests for comparing the cumulative risk incidence of a competing risk. Ann Stat 16: 1141–1154.
22. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3: 1–150.
23. BellM, GranathF, SchonS, EkbomA, MartlingCR (2007) Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 33: 773–780.
24. KlausenK, Borch-JohnsenK, Feldt-RasmussenB, JensenG, ClausenP, et al. (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32–35.
25. AstorBC, MatsushitaK, GansevoortRT, van der VeldeM, WoodwardM, et al. (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79: 1331–1340.
26. ChadbanSJ, BrigantiEM, KerrPG, DunstanDW, WelbornTA, et al. (2003) Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 14: S131–138.
27. CoreshJ, SelvinE, StevensLA, ManziJ, KusekJW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047.
28. TonelliM, MuntnerP, LloydA, MannsBJ, JamesMT, et al. (2011) Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med 154: 12–21.
29. DelannoyB, FloccardB, ThiolliereF, KaakiM, BadetM, et al. (2009) Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study. Intensive Care Med 35: 1907–1915.
30. ChowFY, BrigantiEM, KerrPG, ChadbanSJ, ZimmetPZ, et al. (2003) Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Diseases 41: 596–604.
31. LiemYS, BoschJL, HuninkMG (2008) Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 11: 733–741.
32. AngusDC, ClermontG, Linde-ZwirbleWT, MusthafaAA, DremsizovTT, et al. (2006) Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med 34: 2883–2890.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 2
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Obstructive Sleep Apnea and Risk of Cardiovascular Events and All-Cause Mortality: A Decade-Long Historical Cohort Study
- Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap
- Quantitative Measurement of Melanoma Spread in Sentinel Lymph Nodes and Survival
- Physicians as Fundraisers: Medical Philanthropy and the Doctor-Patient Relationship